Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
GE Logiq E10 clinical ultrasound scanner
United Therapeutics Europe Ltd
Breast Tumor
1 trial -
Gabapentin
United Therapeutics Europe Ltd
Sciatica
1 trial -
Gastrodin Injection
The First People's Hospital of Lianyungang
Sensorineural Hearing Loss
1 trial -
Gemcitabine
HALOZYME THERAPEUTICS, INC.
Pancreatic Cancer
1 trial -
Gemcitabine, cisplatin
The First People's Hospital of Lianyungang
Bladder Cancer
1 trial -
Gene detection of therapeutic drugs for chronic cardiovascular and cerebrovascular diseases
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension,Essential
1 trial -
General Anesthesia
United Therapeutics Europe Ltd
Facial Injuries
1 trial -
Generic cetrorelix acetate
NORTHWEST BIOTHERAPEUTICS INC
Infertility
1 trial -
Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B)
United Therapeutics Europe Ltd
Maturity-onset Diabetes of the Young
1 trial -
Ginkgo Biloba Extract
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Glutamine
United Therapeutics Europe Ltd
Hemorrhagic Shock
1 trial -
GnRH-a
The First People's Hospital of Lianyungang
Infertility, Female
1 trial -
GnRH-a
The First People's Hospital of Lianyungang
Clinical Pregnancy Rate
1 trial -
GnRH-a-1M
The First People's Hospital of Lianyungang
Adenomyosis of Uterus
1 trial -
GnRHa
The First People's Hospital of Lianyungang
Cesarean Scar Diverticula
1 trial -
Goji berry
United Therapeutics Europe Ltd
Age-Related Macular Degeneration
1 trial -
Goserelin
The First People's Hospital of Lianyungang
Allogeneic Haematopoietic Stem Cell Transplantation
1 trial -
Grain-Fed Beef Hamburger
United Therapeutics Europe Ltd
Inflammatory Response
1 trial -
Green Tea Extract
United Therapeutics Europe Ltd
Dysbiosis
1 trial -
Group S: sugammadex injection
Hospital Authority, Hong Kong
Head and Neck Surgery
1 trial -
Guideline-directed medical therapy
The First People's Hospital of Lianyungang
Heart Failure With Reduced Ejection Fraction
1 trial -
HFMS, MRC, ACTIVLIM, PedsQl-4.0
United Therapeutics Europe Ltd
Flaccid Hemiplegia
1 trial -
HG204
The First People's Hospital of Lianyungang
MECP2 Duplication Syndrome
1 trial -
HIV self test
United Therapeutics Europe Ltd
HIV Infections
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources